CSL Limited (OTCMKTS:CSLLY) Short Interest Update

CSL Limited (OTCMKTS:CSLLY) was the recipient of a large increase in short interest in December. As of December 31st, there was short interest totalling 11,800 shares, an increase of 151.1% from the December 15th total of 4,700 shares. Based on an average trading volume of 159,800 shares, the days-to-cover ratio is currently 0.1 days.

CSL Price Performance

Shares of OTCMKTS CSLLY traded down $0.74 during trading hours on Tuesday, hitting $86.39. 87,325 shares of the stock were exchanged, compared to its average volume of 60,646. The company has a current ratio of 2.18, a quick ratio of 0.97 and a debt-to-equity ratio of 0.58. The firm has a fifty day moving average price of $89.69 and a 200-day moving average price of $96.77. CSL has a 12 month low of $83.31 and a 12 month high of $109.00.

About CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.